While physicists have been sharing pre-publication results for some time, biologists have been slower to follow suit, but they are increasingly embracing preprints, Wired reports.
It notes that when BioRxiv began in 2013, about 50 papers were added each month and that that figure is now 1,000 papers a month.
Registering provides access to this and other free content.
Already have an account?Login Now.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.